Advertisement

Topics

Step Therapy For Anti-Inflammatories, ESAs Coming To UnitedHealthcare Medicare Plans

13:45 EDT 12 Oct 2018 | SCRIP

Remicade, Procrit, Aranesp and biosimilars will be subject to step therapy in limited number of Medicare Advantage plans in 2019.

      

Related Stories

 

Original Article: Step Therapy For Anti-Inflammatories, ESAs Coming To UnitedHealthcare Medicare Plans

NEXT ARTICLE

More From BioPortfolio on "Step Therapy For Anti-Inflammatories, ESAs Coming To UnitedHealthcare Medicare Plans"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...